{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:42:50Z","timestamp":1790725370518,"version":"4.1.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\n Background<\/jats:title>\n \n Sensitive and high throughput molecular detection assays are essential during the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vast majority of the SARS-CoV-2 molecular assays use nasopharyngeal swab (NPS) or oropharyngeal swab (OPS) specimens collected from suspected individuals. However, using NPS or OPS as specimens has apparent drawbacks, e.g. the collection procedures for NPS or OPS specimens can be uncomfortable to some people and may cause sneezing and coughing which in turn generate droplets and\/or aerosol particles that are of risk to healthcare workers, requiring heavy use of personal protective equipment. There have been recent studies indicating that self-collected saliva specimens can be used for molecular detection of SARS-CoV-2 and provides more comfort and ease of use for the patients. Here we report the performance of QuantiVirus\n \u2122<\/jats:sup>\n SARS-CoV-2 test using saliva as the testing specimens with or without pooling.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Development and validation studies were conducted following FDA-EUA and molecular assay validation guidelines. Using SeraCare Accuplex SARS-CoV-2 reference panel, the limit of detection (LOD) and clinical performance studies were performed with the QuantiVirus\n \u2122<\/jats:sup>\n SARS-CoV-2 test. For clinical evaluation, 85 known positive and 90 known negative clinical NPS samples were tested. Additionally, twenty paired NPS and saliva samples collected from recovering COVID-19 patients were tested and the results were further compared to that of the Abbott m2000 SARS-CoV-2 PCR assay. Results of community collected 389 saliva samples for COVID-19 screening by QuantiVirus\n \u2122<\/jats:sup>\n SARS-CoV-2 test were also obtained and analyzed. Additionally, testing of pooled saliva samples was evaluated.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The LOD for the QuantiVirus\n \u2122<\/jats:sup>\n SARS-CoV-2 test was confirmed to be 100\u2013200 copies\/mL. The clinical performance studies using contrived saliva samples indicated that the positive percentage agreement (PPA) of the QuantiVirus\n \u2122<\/jats:sup>\n SARS-CoV-2 test is 100% at 1xLOD, 1.5xLOD and 2.5xLOD. No cross-reactivity was observed for the QuantiVirus\n \u2122<\/jats:sup>\n SARS-CoV-2 test with common respiratory pathogens. Testing of clinical samples showed a positive percentage agreement (PPA) of 100% (95% CI: 94.6% to 100%) and a negative percentage agreement (NPA) of 98.9% (95% CI: 93.1% to 99.9%). QuantiVirus\n \u2122<\/jats:sup>\n SARS CoV-2 test had 80% concordance rate and no significant difference (\n p<\/jats:italic>\n = 0.13) between paired saliva and NPS specimens by Wilcoxon matched pairs signed rank test. Positive test rate was 1.79% for 389 saliva specimens collected from local communities for COVID-19 screening. Preliminary data showed that saliva sample pooling up to 6 samples (1:6 pooling) for SARS-CoV-2 detection is feasible (sensitivity 94.8% and specificity 100%).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n \n The studies demonstrated that the QuantiVirus\n \u2122<\/jats:sup>\n SARS-CoV-2 test has a LOD of 200 copies\/mL in contrived saliva samples. The clinical performance of saliva-based testing is comparable to that of NPS-based testing. Pooling of saliva specimens for SARS-CoV-2 detection is feasible. Saliva based and high-throughput QuantiVirus\n \u2122<\/jats:sup>\n SARS-CoV-2 test offers a highly desirable testing platform during the ongoing COVID-19 pandemic.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0243183","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T14:02:49Z","timestamp":1614088969000},"page":"e0243183","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Saliva as a testing specimen with or without pooling for SARS-CoV-2 detection by multiplex RT-PCR test"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2385-1006","authenticated-orcid":true,"given":"Qing","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Loginova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Madej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9896-0605","authenticated-orcid":true,"given":"Joseph K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5906-2543","authenticated-orcid":true,"given":"Chuanyi M.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4552-6079","authenticated-orcid":true,"given":"Michael Y.","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"pone.0243183.ref001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"N Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0243183.ref002","unstructured":"World Health Organization (WHO). Coronavirus. Geneva: WHO; 2020 [Accessed 21 Jan 2020]. https:\/\/www.who.int\/health-topics\/coronavirus"},{"key":"pone.0243183.ref003","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Q Li","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0243183.ref004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"N Chen","year":"2020","journal-title":"Lancet"},{"key":"pone.0243183.ref005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"JF Chan","year":"2020","journal-title":"Lancet"},{"key":"pone.0243183.ref006","first-page":"1","article-title":"Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2","author":"EC Leung","year":"2020","journal-title":"J Med Virol"},{"key":"pone.0243183.ref007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"R W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"pone.0243183.ref008","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","article-title":"Temporal dynamics in viral shedding and transmissibility of COVID-19","volume":"26","author":"X He","year":"2020","journal-title":"Nat Med"},{"key":"pone.0243183.ref009","doi-asserted-by":"crossref","first-page":"e01438","DOI":"10.1128\/JCM.01438-20","article-title":"Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19","volume":"58","author":"M Nagura-Ikeda","year":"2020","journal-title":"J Clin Microbiol"},{"key":"pone.0243183.ref010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/infdis\/jiaa370","article-title":"Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results","volume":"222","author":"N Kinloch","year":"2020","journal-title":"J Infect Dis"},{"key":"pone.0243183.ref011","article-title":"Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs","author":"A Wyllie","year":"2020","journal-title":"medRxiv"},{"key":"pone.0243183.ref012","article-title":"Self-collected anterior nasal and saliva specimens versus healthcare worker-collected nasopharyngeal swabs for the molecular detection of SARS-CoV-2","author":"KE Hanson","year":"2020","journal-title":"J. Clin. Microbiol"},{"key":"pone.0243183.ref013","unstructured":"Centre for Health Protection. Severe respiratory disease associated with a novel infectious agent\u2014letters to doctors. (2020). Accessed: February 5, 2020: https:\/\/www.chp.gov.hk\/en\/miniweb\/letters\/100063.html."},{"key":"pone.0243183.ref014","unstructured":"FDA EUA, Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2 https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/vitro-diagnostics-euas#umbrella-molecular"},{"key":"pone.0243183.ref015","first-page":"e7708","article-title":"A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19","volume":"12","author":"T Sri Santosh","year":"2020","journal-title":"Cureus"},{"key":"pone.0243183.ref016","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/cid\/ciaa149","article-title":"Consistent Detection of 2019 Novel Coronavirus in Saliva","volume":"71","author":"KK To","year":"2020","journal-title":"Clin. Infect. Dis"},{"key":"pone.0243183.ref017","unstructured":"Chen L, Zhao J, Peng J, Li X, Deng X, Geng Z. et al. Detection of 2019-nCoV in Saliva and Characterization of Oral Symptoms in COVID-19 Patients. (2020) https:\/\/ssrn.com\/abstract=3557140"},{"key":"pone.0243183.ref018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41368-020-0080-z","article-title":"Saliva: potential diagnostic value and transmission of 2019-nCoV","volume":"12","author":"R Xu","year":"2020","journal-title":"International Journal of Oral Science"},{"key":"pone.0243183.ref019","unstructured":"FDA SARS-CoV-2 Reference Panel Comparative Data https:\/\/www.fda.gov\/medical-devices\/coronavirus-covid-19-and-medical-devices\/sars-cov-2-reference-panel-comparative-data?from=singlemessage&isappinstalled=0"},{"key":"pone.0243183.ref020","article-title":"SalivaDirect: Simple and sensitive molecular diagnostic test for SARS-COV-2 surveillance","author":"C Vogels","year":"2020","journal-title":"MedRxiv"},{"key":"pone.0243183.ref021","doi-asserted-by":"crossref","first-page":"104567","DOI":"10.1016\/j.jcv.2020.104567","article-title":"Challenges in use of saliva for detection of SARS-COV-2 RNA in symptomatic outpatients","volume":"130","author":"M Landy","year":"2020","journal-title":"J. Clincal Virology"},{"key":"pone.0243183.ref022","article-title":"Automated molecular testing of saliva for SARS-COV-2 detection","author":"N Matic","year":"2020","journal-title":"MedRxiV"},{"key":"pone.0243183.ref023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40249-020-00728-w","article-title":"Saliva as a diagnostic specimen for detection of SARS-CoV-2 in suspected patients: a scoping review","volume":"9","author":"O Fakheran","year":"2020","journal-title":"Infectious Diseases of Poverty"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T14:03:12Z","timestamp":1614088992000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243183"}},"subtitle":[],"editor":[{"given":"Ruslan","family":"Kalendar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0243183","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.27.20219196","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,23]]}}}